BEST UNLIMITED TURBO LONG CERTIFICATE - JOHNSON & JOHNSON Share Price

Certificat

QS43S

DE000SV6YV36

Market Closed - Euronext Paris 17:30:01 21/05/2024 BST
2.872 EUR -3.69% Intraday chart for BEST UNLIMITED TURBO LONG CERTIFICATE - JOHNSON & JOHNSON
Current month+19.54%
1 month+12.22%
Date Price Change
21/05/24 2.872 -3.69%
20/05/24 2.982 -4.24%
17/05/24 3.114 +2.70%
16/05/24 3.032 +4.37%
15/05/24 2.905 +3.31%

Real-time Euronext Paris

Last update May 21, 2024 at 05:30 pm

More quotes

Static data

Product typeCertificat Turbo
Buy / SellCALL
Underlying JOHNSON & JOHNSON
IssuerLogo Issuer Société Générale Société Générale
QS43S
ISINDE000SV6YV36
Date issued 01/06/2023
Strike 120.4 $
Maturity Unlimited
Parity 10 : 1
Emission price 4.1
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 5.73
Lowest since issue 2.25
Spread 0.005
Spread %0.17%

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
151.3 USD
Average target price
173.3 USD
Spread / Average Target
+14.54%
Consensus
  1. Stock Market
  2. Certificates
  3. QS43S Certificat